Skip to main content

Table 2 Cox proportional hazard regression analysis on mortality of diabetic patients after first acute myocardial infarction

From: The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

Characteristics (all, N = 5344) HR (95% CI)
Sex (male vs female) 0.98 (0.89–1.07)
Age (65 ≤ age < 75 vs age <65) 1.71 (1.5–1.96)***
Age (age ≥75 vs age <65) 2.51 (2.2–2.85)***
Hypertension (yes vs no) 1.2 (1.06–1.37)**
Peripheral vascular disease (yes vs no) 1.57 (1.34–1.84)***
Heart failure (yes vs no) 1.35 (1.23–1.49)***
End stage renal disease (yes vs no) 1.76 (1.51–2.06)***
Cerebrovascular disease (yes vs no) 1.33 (1.21–1.47)***
Chronic obstructive pulmonary disease (yes vs no) 1.33 (1.16–1.52)***
Percutaneous coronary intervention (yes vs no) 0.54 (0.49–0.6)***
Any antiplatelet (yes vs no) 0.58 (0.49–0.7)***
ACEI or ARB (yes vs no) 0.72 (0.65–0.8)***
β-Blocker (yes vs no) 0.79 (0.71–0.87)***
Heparin or low molecular weight heparin (yes vs no) 1.02 (0.91–1.15)
α-Glucosidase (yes vs no) 0.95 (0.83–1.08)
Glinides (yes vs no) 1.05 (0.94–1.18)
Metformin (yes vs no) 0.77 (0.68–0.86)***
Sulfonylureas (yes vs no) 0.91 (0.82–1.01)
Thiazolidinedione (yes vs no) 0.79 (0.59–1.04)
DPP-4 inhibitor (yes vs no) 0.86 (0.78–0.95)**
  1. ** P < 0.01, *** P < 0.001